Treatment of Localized Low Grade Lymphomas
NCT00536458 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2007-11-01
Summary
To compare localiezd radiotherapy to localized radiotherapy followed by 6 cycles of chemotherapy in the treatment of localiezd low grade lymphoma
Conditions
- Lymphoma, Low-Grade
Interventions
- PROCEDURE
-
radiotherapy
mini chep+ radiotherapy
- DRUG
-
MINI CHEP
chemotherapy minichep 6 courses
Sponsors & Collaborators
-
French Innovative Leukemia Organisation
lead OTHER
Principal Investigators
-
eric DECONINCK, MD PhD · French Innovative Leukemia Organisation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-03-31
- Completion
- 2006-12-31
Countries
- France
Study Locations
More Related Trials
-
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
NCT05621096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Post-CAR T in Refractory Lymphoma
NCT04473937 ·Status: TERMINATED ·Phase: NA
-
Treatment of Disseminated High Grade Lymphoma
NCT00536393 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research
NCT06049381 ·Status: NOT_YET_RECRUITING
-
Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma
NCT01226849 ·Status: COMPLETED ·Phase: PHASE1
-
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
NCT07215585 ·Status: RECRUITING ·Phase: PHASE3
-
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
NCT03985696 ·Status: UNKNOWN ·Phase: NA
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
NCT00003204 ·Status: COMPLETED ·Phase: PHASE3
-
Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma
NCT07210749 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
NCT00561379 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 ·Status: COMPLETED ·Phase: PHASE2
-
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma
NCT00412997 ·Status: COMPLETED ·Phase: PHASE1
-
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
NCT01856192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
RadiothErapy priMIng for CAR-T
NCT04726787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
NCT00290667 ·Status: COMPLETED ·Phase: PHASE2
-
Low Grade Lymphoma
NCT01698866 ·Status: UNKNOWN ·Phase: PHASE4
-
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
NCT00278408 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
NCT01324596 ·Status: COMPLETED ·Phase: PHASE3
-
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT01745354 ·Status: TERMINATED ·Phase: PHASE1
-
Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant
NCT02109809 ·Status: TERMINATED ·Phase: NA
-
Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma
NCT00794261 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
NCT05800405 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
NCT00906841 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
NCT00209222 ·Status: UNKNOWN ·Phase: PHASE3